The use of Left Ventricular Ejection Fraction in the Diagnosis and Management of Heart Failure. A Clinical Consensus Statement of the Heart Failure Association (HFA) of the ESC, the Heart Failure Society of America (HFSA), and the Japanese Heart Failure Society (JHFS).


Por: Rosano GMC, Teerlink JR, Kinugawa K, Bayes-Genis A, Chioncel O, Fang J, Greenberg B, Ibrahim NE, Imamura T, Inomata T, Kuwahara K, Moura B, Onwuanyi A, Sato N, Savarese G, Sakata Y, Sweitzer N, Wilcox J, Yamamoto K, Metra M and Coats AJS

Ahead of Print: 9 abr 2025
Resumen:
This clinical consensus statement revisits the role of left ventricular ejection fraction (LVEF) as a measurement of cardiac function, a prognostic marker and a major criterion to classify patients with heart failure, and gives new advice for clinical practice. Heart failure is traditionally classified on the basis of LVEF thresholds and this has major implications for treatment recommendations. However, the reproducibility of LVEF measurement is poor and its prognostic and diagnostic value lessens when it is above 45%, with no relationship with the severity of either cardiac dysfunction or outcomes at higher values. These limitations dictate the need for a more comprehensive approach to classify and assess heart failure focusing more on the trajectory of LVEF rather than to its absolute value. Furthermore, the assessment of LVEF is not required for the initiation of treatments like sodium-glucose cotransporter 2 inhibitors, mineralocorticoid receptor antagonists and diuretics in patients with suspected de novo heart failure and elevated N-terminal pro-B-type natriuretic peptide levels. Future research utilizing advanced imaging techniques and biomarkers which can better characterize myocardial structure, metabolism and performance may facilitate the identification of alternative therapeutic targets and better ways to monitor heart failure therapies across the entire spectrum of LVEF.

Filiaciones:
Rosano GMC:
 San Raffaele Open University of Rome, Rome, Italy

 Cardiology, San Raffaele Cassino Hospital, Cassino, Italy

Teerlink JR:
 University of California San Francisco, San Francisco, CA, USA

Kinugawa K:
 University of Toyama, Toyama, Japan

:
 Hospital Universitari Germans Trias i Pujol Badalona CIBERCV, Barcelona, Spain

Chioncel O:
 Emergency Institute for Cardiovascular Diseases 'Prof. C.C. Iliescu', Bucharest, Romania

Fang J:
 University of Utah Hospital Salt Lake City, UT, USA

Greenberg B:
 University of California San Diego, San Diego, CA, USA

Ibrahim NE:
 Brigham and Women's Hospital, Boston, MA, USA

Imamura T:
 University of Toyama, Toyama, Japan

Inomata T:
 Kitasato University Kitasato Institute Hospital, Tokyo, Japan

Kuwahara K:
 Shinshu University Hospital Matsumoto, Japan

Moura B:
 Military Hospital Porto, Portugal

Onwuanyi A:
 Grady Memorial Hospital Atlanta, GA, USA

Sato N:
 Nippon Medical School, Tokyo, Japan

Savarese G:
 Karolinska University Hospital, Stockholm, Sweden

Sakata Y:
 National Cerebral and Cardiovascular, Center Osaka, Japan

Sweitzer N:
 Washington University School of Medicine, St. Louis, MO, USA

Wilcox J:
 Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Yamamoto K:
 Tottori University Yonago, Japan

Metra M:
 University of Brescia, Brescia, Italy

Coats AJS:
 University of Warwick, Coventry, UK
ISSN: 10719164





Journal of Cardiac Failure
Editorial
Churchill Livingstone, CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA, Estados Unidos America
Tipo de documento: Article
Volumen: Número:
Páginas:
ID de PubMed: 40268622

MÉTRICAS